A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

Researchers from the Max Planck Institute of Biochemistry have discovered the mechanism behind an important step in the life ...

Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its inner core into the host cell's nuclear membrane. The findings ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...

Mice whose brains express the HIV-1 Tat protein show a heightened response to the drug and appear more vulnerable to relapse. Kerry served as The Scientist’s news director until 2021. Before joining ...

Four crew members will embark on a new long-duration science expedition when they launch to the International Space Station ...

A revolutionary advancement in HIV prevention technology stands at a critical crossroads as recent policy decisions threaten to undermine progress.

In a ceremony held last month, the 2024 Louisa Gross Horwitz Prize was awarded to Wesley Sundquist, PhD, Leo T. and Barbara K ...

CD8 + T cells can recognize and then kill HIV-infected cells following the presentation of fragments of viral proteins (epitopes) in the peptide-binding groove of MHC class I molecules on the ...